Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells

Cell Research

Volumn 11, Issue 4, 2001, Pages 311-315

  Li, Hong Liang ^a   Ye, Kai He ^a   Zhang, Hai Wei ^a   Luo, Ying Ru ^a   Ren, Xian Da ^a   Xiong, Ai Hua ^a   Situ, Rui ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Agarose gel electrophoresis; Apoptosis; Flow cytometry; Heparin; Protein kinase C (PKC)

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; HEPARIN; MYC PROTEIN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; HUMAN; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA; HEPARIN; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR CELLS, CULTURED;

EID: 0035748982     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290101     Document Type: Article

References (25)

1. Mandal AK, Lyden TW, Saklayen MG. Heparin lowers blood pressure biological and clinical perspectives. Kidney Int 1995; 47:1017-24.
2. Neison RM, Cecconi O, Roberts G, Aruffo A, Linhard RJ, Bcvilaqua MP. Heparin oligosaccharides bind L-and P-selection and inhibit acute inflammation. Blood 1993; 82:3253-61.
3. Ley K, Cerrito M, Arfors KE. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol 1991; 260:H1667-H1673.
4. Bazzoni G, Beltran-Nunez A, Mascellani G. Effect of heparin dermatan sulfate and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 1993; 121:268-75.
5. Laghi-Pasini F, Pasqui AL, Ceccatelli L, Capecchi PL. Heparin inhibition of polymorphonuclear leukocyte action in vitro: A possible pharmacological approach to granulocyte-mediated vascular damage. Thromb Res 1984; 35:527-37.
6. Groggel GC, Marinides GN, Hovingh P, Hammond E. Inhibition of rat mesangial cell growth by heparin sulfate. Am J Physiol 1990; 258:F259-F265.
7. Krramura M, Mitaral T, Maruyama N, Nagasawa R. Mesangial cell behavior in a three-dimensional extracellular matrix. Kidney Int 1991; 40:653-61.
8. Gunji Y, Gorelick E. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Cancer Res 1988; 48:729-36.
9. Markus G. The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Thromb Hemost 1984; 10:61-72.
10. Beuth J, Ko HL, Pulverer G, Uhlenbrock G, Pichlmaier H. Importance of lectins for the prevention of bacterial infections and cancer metastasis. Glyconjugates 1995; 12:1-6.
11. Vlodavssky I, Ishai-Michaels R, Morhren M, Bar-Shavit R, Catani R, Ekre H-P, et al. Modulation of meovascularization and metastasis by species of heparin. Adv Exp Biol Med 1992; 313:317-27.
12. Busch SJ, Martin GA, Barnhart RL, Jackson RL. Transrepressor activity of nuclear glycosaminoglycans on fos and jun/AP-1 oncoprotein-mediated transcription. J Cell Biol 1992; 116:31-42.
13. Manaster J, Chezar J, Schurtz-Swirski R, Shapiro G, Tendler Y, Kristal B, Shasha SM, Sela S. Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol 1996; 94:48-55.
14. Lshikawa Y, Kitanura M. Inhibition of glomerular cell apoptosis by heparin. Kidney Int 1999; 56:954-63.
15. Yang L. Yang Y-C. Heparin inhibits the expression of interleukin-11 and granulocyte-macrophage colony stimulating factor in primate bone marrow stromal fibroblasts through mRNA destabilization. Blood 1995; 86:2526-33.
16. Fang CM, Shi C, Xu YH. Deregulated c-myc expression in quiescent CHO cells induces target gene transcription and subsequent apoptotic phenotype. Cell Research 1999; 9:305-14.
17. Fan XQ, YJ Guo. Apoptosis in oncology. Cell Research 2000; 11:1-7.
18. Harrington E, Fanidi A, Bennett M, Evan G. Modulation of myc-induced apoptosis by specific cytokine. EMBO J 1994; 13:3286-95.
19. Fanidi A, Harrington E, Evan G. Cooperative interaction between c-myc and bcl-2 proti-oncogenes. Nature 1992; 359:554-6.
20. Xu G, Gai Q, James CB. Protein kinase C inhibits transcription from the RNA poymerase III promoter of the human c-myc gene. Cancer Lett 1998; 123:199-205.
21. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1-6.
22. Chang YC, Xu YH. Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells. Cell Research 2000; 10:237-42.
23. Yin XM. Signal transduction mediated by Bid, a prodeath Bcl-2 family. Cell Research 2000; 10:161-7.
24. Sakamuro D, Eviner V, Elliott KJ, Show L, White E. C-myc induces apoptosis in epithelial cell by both p53-dependent and p53-independent mechanisms. Oncogene 1995; 11:2411-8.
25. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74:609-19.